ACADIA Pharmaceuticals Inc. (ACAD) Tuesday said first-quarter loss narrowed to $6.1 million or $0.08 per share from $6.2 million or $0.12 per share in the comparable quarter last year.
On average, nine analysts polled by Thomson Reuters expected the company to report a loss of $0.08 per share for the quarter. Analysts' estimates typically exclude special items.
Revenues totaled $417 thousand, down from $450 thousand last year. Analysts expected revenues of $450 thousand.
Operating expenses decreased to $6.58 million from $6.68 million last year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.